Alison A. Carter

A Phase II, Double-Blind, Placebo-Controlled, Ascending-Dose Study of Eritoran (E5564), a Lipid A Antagonist, in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass

Elliott Bennett‐Guerrero, Hilary P. Grocott, Jerrold H. Levy et al. · Anesthesia & Analgesia · 2007 · 65 citations

Dynamic tumor modeling of the dose–response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial

Andrew M. Stein, Wenping Wang, Alison A. Carter et al. · BMC Cancer · 2012 · 37 citations · Full text

Characterization of Isoprenaline- and Salmeterol-Stimulated Interactions between β2-Adrenoceptors and β-Arrestin 2 Using β-Galactosidase Complementation in C2C12 Cells

Alison A. Carter, Stephen J. Hill · Journal of Pharmacology and Experimental Therapeutics · 2005 · 34 citations · Full text

Rapid singular value decomposition for time-domain analysis of magnetic resonance signals by use of the lanczos algorithm

Glenn L. Millhauser, Alison A. Carter, David J. Schneider et al. · Journal of Magnetic Resonance (1969) · 1989 · 18 citations

Numerical Analysis, Lanczos Algorithm, Magnetic Resonance Signals +10

Population Pharmacokinetics: Fundamentals, Methods and Applications

Sara Rosenbaum, Alison A. Carter, Michael N. Dudley · Drug Development and Industrial Pharmacy · 1995 · 15 citations

Pharmacological Study, Pharmacodynamics, Pharmacology +9